Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
Year: 2002
Type: article
Source: PubMed
Authors: Chris Waskewich, Rosalyn D Blumenthal, Honglan Li, Rhona Stein, David M Goldenberg, Jack Burton
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1576582769